|
On April 15, 2024, Fresenius Kabi announced the U.S. launch of its ACTEMRA biosimilar, TYENNE (tocilizumab-aazg) as an intravenous formulation.
Category:
News and Media
The potential mega merger would give BHP access to Anglo American's copper assets.
Category:
News and Media
The school in question is well known for its strict behavior policies and regimented school day, with its headteacher boasting it is the "strictest school in Britain".
Category:
News and Media
All news |
||||||||||||||||||
|